This is the case of the epithelial growth factor receptor (EGFR) gene, which is overrepresented in lung cancer cells, with the L878R mutation being distributed in approximately 40% of EGFR-mutated lung cancers [60]. The gene discussed is EGFR; the disease is lung cancer.